Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
AOD-9604 targets fat loss, while CJC-1295 and Ipamorelin work together to enhance and sustain natural growth hormone production, promoting lean muscle gain and overall metabolic improvement
ClinicalTrials.gov (2016)
The endurance support is noticeable, but the results are not as dramatic as anticipated
Key advances In the SURMOUNT-1 trial for obesity, adults with overweight or obesity without type 2 diabetes mellitus achieved placebo-subtracted weight loss of up to 20% after 72 weeks of the GLP1GIP receptor co-agonist tirzepatide, with a similar safety profile to high-dose semaglutide 5
For the first time in years scientists are reporting that life expectancy in adults and children are now reduced due to obesity (6)
US$ 19.99
US$ 24.32
US$ 26.95
US$ 26.95
US$ 20.29
US$ 20.43
US$ 28.14
US$ 25.16
